Journal article
Association of HIV-1 Envelope-Specific Breast Milk IgA Responses with Reduced Risk of Postnatal Mother-to-Child Transmission of HIV-1
Journal of virology, Vol.89(19), pp.9952-9961
10/01/2015
DOI: 10.1128/JVI.01560-15
PMCID: PMC4577885
PMID: 26202232
Abstract
Infants born to HIV-1-infected mothers in resource-limited areas where replacement feeding is unsafe and impractical are repeatedly exposed to HIV-1 throughout breastfeeding. Despite this, the majority of infants do not contract HIV-1 postnatally, even in the absence of maternal antiretroviral therapy. This suggests that immune factors in breast milk of HIV-1-infected mothers help to limit vertical transmission. We compared the HIV-1 envelope-specific breast milk and plasma antibody responses of clade C HIV-1-infected postnatally transmitting and nontransmitting mothers in the control arm of the Malawi-based Breastfeeding Antiretrovirals and Nutrition Study using multivariable logistic regression modeling. We found no association between milk or plasma neutralization activity, antibody-dependent cell-mediated cytotoxicity, or HIV-1 envelope-specific IgG responses and postnatal transmission risk. While the envelope-specific breast milk and plasma IgA responses also did not reach significance in predicting postnatal transmission risk in the primary model after correction for multiple comparisons, subsequent exploratory analysis using two distinct assay methodologies demonstrated that the magnitudes of breast milk total and secretory IgA responses against a consensus HIV-1 envelope gp140 (B.con env03) were associated with reduced postnatal transmission risk. These results suggest a protective role for mucosal HIV-1 envelope-specific IgA responses in the context of postnatal virus transmission. This finding supports further investigations into the mechanisms by which mucosal IgA reduces risk of HIV-1 transmission via breast milk and into immune interventions aimed at enhancing this response.
Infants born to HIV-1-infected mothers are repeatedly exposed to the virus in breast milk. Remarkably, the transmission rate is low, suggesting that immune factors in the breast milk of HIV-1-infected mothers help to limit transmission. We compared the antibody responses in plasma and breast milk of HIV-1-transmitting and -nontransmitting mothers to identify responses that correlated with reduced risk of postnatal HIV-1 transmission. We found that neither plasma nor breast milk IgG antibody responses were associated with risk of HIV-1 transmission. In contrast, the magnitudes of the breast milk IgA and secretory IgA responses against HIV-1 envelope proteins were associated with reduced risk of postnatal HIV-1 transmission. The results of this study support further investigations of the mechanisms by which mucosal IgA may reduce the risk of HIV-1 transmission via breastfeeding and the development of strategies to enhance milk envelope-specific IgA responses to reduce mother-to-child HIV transmission and promote an HIV-free generation.
Details
- Title: Subtitle
- Association of HIV-1 Envelope-Specific Breast Milk IgA Responses with Reduced Risk of Postnatal Mother-to-Child Transmission of HIV-1
- Creators
- Justin Pollara - Duke UniversityErin McGuire - Duke UniversityGenevieve G Fouda - Duke UniversityWes Rountree - Duke UniversityJosh Eudailey - Duke UniversityR Glenn Overman - Duke UniversityKelly E Seaton - Duke UniversityAaron Deal - Duke UniversityR Whitney Edwards - Duke UniversityGerald Tegha - The University of North Carolina Project, Lilongwe, MalawiDeborah Kamwendo - The University of North Carolina Project, Lilongwe, MalawiJacob Kumwenda - The University of North Carolina Project, Lilongwe, MalawiJulie A E Nelson - University of North Carolina at Chapel HillHua-Xin Liao - Duke UniversityChristie Brinkley - Duke UniversityThomas N Denny - Duke UniversityChristina Ochsenbauer - University of Alabama at BirminghamSascha Ellington - National Center for Chronic Disease Prevention and Health PromotionCaroline C King - Centers for Disease Control and PreventionDenise J Jamieson - National Center for Chronic Disease Prevention and Health PromotionCharles van der Horst - University of North Carolina at Chapel HillAthena P Kourtis - Centers for Disease Control and PreventionGeorgia D Tomaras - Duke UniversityGuido Ferrari - Duke UniversitySallie R Permar - Duke University
- Resource Type
- Journal article
- Publication Details
- Journal of virology, Vol.89(19), pp.9952-9961
- DOI
- 10.1128/JVI.01560-15
- PMID
- 26202232
- PMCID
- PMC4577885
- NLM abbreviation
- J Virol
- ISSN
- 0022-538X
- eISSN
- 1098-5514
- Grant note
- U19 AI067854 / NIAID NIH HHS R24 TW00798 / FIC NIH HHS SIP 26-04 U48-DP000059-01 / NCCDPHP CDC HHS P30 AI064518 / NIAID NIH HHS AI100645 / NIAID NIH HHS UM1 AI100645 / NIAID NIH HHS SIP 13-01U48-CCU409660-09 / PHS HHS P30-AI50410 / NIAID NIH HHS 5P30AI064518 / NIAID NIH HHS R01 AI106380 / NIAID NIH HHS P30 AI027767 / NIAID NIH HHS U48 DP000059 / NCCDPHP CDC HHS SIP 22-09 U48-DP001944-01 / NCCDPHP CDC HHS 5P30 AI050410 / NIAID NIH HHS P30 AI050410 / NIAID NIH HHS DHHS/NIH/FIC 2-D43 TW01039-06 / FIC NIH HHS U48 DP001944 / NCCDPHP CDC HHS AI06380 / NIAID NIH HHS
- Language
- English
- Date published
- 10/01/2015
- Academic Unit
- Obstetrics and Gynecology; VPMA - Administration
- Record Identifier
- 9984446408202771
Metrics
25 Record Views